These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7956667)

  • 41. Cytologic features of villoglandular adenocarcinoma of the uterine cervix: comparison with typical endocervical adenocarcinoma with a villoglandular component and papillary serous carcinoma.
    Chang WC; Matisic JP; Zhou C; Thomson T; Clement PB; Hayes MM
    Cancer; 1999 Feb; 87(1):5-11. PubMed ID: 10096353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the cervical canal with the endocervical brush.
    Hoffman MS; Sterghos S; Gordy LW; Gunasekaran S; Cavanagh D
    Obstet Gynecol; 1993 Oct; 82(4 Pt 1):573-7. PubMed ID: 8377985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of cervical disease history on outcomes of women who have a pap diagnosis of atypical glandular cells of undetermined significance.
    Raab SS; Bishop NS; Zaleski MS
    Gynecol Oncol; 1999 Sep; 74(3):460-4. PubMed ID: 10479510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Cytobrush effect on Pap smear adequacy.
    Davey-Sullivan B; Gearhart J; Evers CG; Cason Z; Replogle WH
    Fam Pract Res J; 1991 Mar; 11(1):57-64. PubMed ID: 2028815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the three most common Papanicolaou smear collection techniques.
    Germain M; Heaton R; Erickson D; Henry M; Nash J; O'Connor D
    Obstet Gynecol; 1994 Aug; 84(2):168-73. PubMed ID: 8041524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women.
    Chhieng DC; Elgert P; Cohen JM; Cangiarella JF
    Cancer; 2001 Feb; 93(1):1-7. PubMed ID: 11241259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conservative management of options for patients with dysplasia involving endocervical margins of cervical cone biopsy specimens.
    Monk A; Pushkin SF; Nelson AL; Gunning JE
    Am J Obstet Gynecol; 1996 Jun; 174(6):1695-9; discussion 1699-700. PubMed ID: 8678129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocervical columnar cell atypia coincident with cervical neoplasia characterized by digital image analysis.
    Rosenthal DL; McLatchie C; Stern E; White BS; Castleman KR
    Acta Cytol; 1982; 26(2):115-20. PubMed ID: 7044016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocervical glandular atypia: a "new" problem for the cytologist.
    Wilbur DC
    Diagn Cytopathol; 1995 Dec; 13(5):463-9. PubMed ID: 8834321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colposcopic screening of women with atypical Papanicolaou smears.
    Kohan S; Noumoff J; Beckman EM; Morris M; Weiner E; Douglas GW
    J Reprod Med; 1985 May; 30(5):383-7. PubMed ID: 4009560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the endocervical brush and the endocervical curettage for the evaluation of the endocervical canal.
    Martin D; Umpierre SA; Villamarzo G; Sánchez O; Sánchez J; Carrodeguas J; Adamsons K
    P R Health Sci J; 1995 Sep; 14(3):195-7. PubMed ID: 8588020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early endocervical glandular neoplasia. I. Histomorphology and cytomorphology.
    Betsill WL; Clark AH
    Acta Cytol; 1986; 30(2):115-26. PubMed ID: 3457503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytobrush and endocervical curettage in the diagnosis of dysplasia and malignancy of the uterine cervix.
    Mogensen ST; Bak M; Dueholm M; Frost L; Knoblauch NO; Praest J; Svanholm H
    Acta Obstet Gynecol Scand; 1997 Jan; 76(1):69-73. PubMed ID: 9033248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Should the Cytobrush be used in routine screening for cervical pathology?
    van Erp EJ; Dersjant-Roorda MC; Arentz NP; Stijnen T; Trimbos JB
    Int J Gynaecol Obstet; 1989 Oct; 30(2):139-44. PubMed ID: 2572484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the endocervical Cytobrush and Cervex-Brush in pregnant women.
    Paraiso MF; Brady K; Helmchen R; Roat TW
    Obstet Gynecol; 1994 Oct; 84(4):539-43. PubMed ID: 8090390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Symposium part 3: Should pathologists diagnose endocervical preneoplastic lesions "less than" adenocarcinoma in situ?: Point.
    Ioffe OB; Sagae S; Moritani S; Dahmoush L; Chen TT; Silverberg SG
    Int J Gynecol Pathol; 2003 Jan; 22(1):18-21. PubMed ID: 12496692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laboratory reliability of the Papanicolaou smear.
    Yobs AR; Swanson RA; Lamotte LC
    Obstet Gynecol; 1985 Feb; 65(2):235-44. PubMed ID: 3969236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histologic follow-up of atypical endocervical cells. Liquid-based, thin-layer preparation vs. conventional Pap smear.
    Wang N; Emancipator SN; Rose P; Rodriguez M; Abdul-Karim FW
    Acta Cytol; 2002; 46(3):453-7. PubMed ID: 12040636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The significance of moderate and severe inflammation on class I Papanicolaou smear.
    Lawley TB; Lee RB; Kapela R
    Obstet Gynecol; 1990 Dec; 76(6):997-9. PubMed ID: 2234731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The value of endocervical curettage in the management of the patient with abnormal cervical cytologic findings.
    Grainger DA; Roberts DK; Wells MM; Horbelt DV
    Am J Obstet Gynecol; 1987 Mar; 156(3):625-8. PubMed ID: 3826211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.